Last reviewed · How we verify
Selective serotonin reuptake inhibitor
Selective serotonin reuptake inhibitor is a Small molecule drug developed by University of Washington. It is currently FDA-approved. Also known as: SSRI, CBT.
Selective serotonin reuptake inhibitors (SSRIs) are a class of small molecule drugs used as antidepressants in the treatment of conditions such as Major Depressive Disorder, Obsessive-Compulsive Disorder, Pain, Chronic, and Social Phobia. They work by modulating serotonin levels in the brain, although the exact mechanism is not specified in the provided facts.
At a glance
| Generic name | Selective serotonin reuptake inhibitor |
|---|---|
| Also known as | SSRI, CBT |
| Sponsor | University of Washington |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study of Electrophysiological Markers of Antidepressants in Major Depressive Disorder (NA)
- Intradermal Acupuncture for Assisting SSRI Dose Reduction in Major Depressive Disorder (NA)
- Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease (PHASE2)
- Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms (PHASE3)
- A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)
- Effect of Virtual Reality on Depression in Adolescent Females (NA)
- MAGNESIUM & SSRI VS SSRI ALONE AMONG PATIENTS OF MAJOR DEPRESSIVE DISORDER (PHASE2)
- Pattern Separation in Major Depressive Disorder (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Selective serotonin reuptake inhibitor CI brief — competitive landscape report
- Selective serotonin reuptake inhibitor updates RSS · CI watch RSS
- University of Washington portfolio CI
Frequently asked questions about Selective serotonin reuptake inhibitor
What is Selective serotonin reuptake inhibitor?
Who makes Selective serotonin reuptake inhibitor?
Is Selective serotonin reuptake inhibitor also known as anything else?
What development phase is Selective serotonin reuptake inhibitor in?
Related
- Manufacturer: University of Washington — full pipeline
- Also known as: SSRI, CBT
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing